Stay updated on Neutron Radiation+Pembrolizumab in Advanced Urothelial Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Neutron Radiation+Pembrolizumab in Advanced Urothelial Carcinoma Clinical Trial page.

Latest updates to the Neutron Radiation+Pembrolizumab in Advanced Urothelial Carcinoma Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.4.3 has been added and Revision: v3.4.2 has been removed.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision: v3.4.2 is now displayed. The funding-lapse notice and the v3.4.1 revision note have been removed.SummaryDifference0.5%

- Check41 days agoChange DetectedA site-wide funding-status notice and a revision update (v3.4.1, replacing v3.4.0) were added. These are administrative changes and do not alter the study content or data on the page; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check48 days agoChange DetectedA glossary display option was added, and the page’s release notes were updated to include 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0'. The previous wording variants for 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' were adjusted for capitalization and phrasing.SummaryDifference0.2%

- Check62 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check83 days agoChange DetectedA new Locations section now lists Kentucky, Missouri, and Pennsylvania, replacing the previous Kentucky Locations, Missouri Locations, and Pennsylvania Locations subsections. The HHS Vulnerability Disclosure link in the footer was removed.SummaryDifference0.5%

Stay in the know with updates to Neutron Radiation+Pembrolizumab in Advanced Urothelial Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neutron Radiation+Pembrolizumab in Advanced Urothelial Carcinoma Clinical Trial page.